
Liminatus Pharma, Inc. Class A Common Stock
LIMNHealthcare|Biotechnology|US
$2.54
-0.09 (-3.42%)
Tangible Book / Share
$0.63
Cash / Share
$6.35
Financing Filings (last 12 months)
4
Shelf registrations / offering prospectuses — latest Jun 24, 2026 (S-1). Possible dilution.
Upcoming Data Readouts (0)
No upcoming completion dates found in active trials.
Recent Press Releases
Liminatus Pharma Regains Compliance with Nasdaq Minimum Bid Price Rule
Sep 29, 2026 · GlobeNewsWire
Liminatus Pharma Engages Synex as Contract Research Organization to Support Phase 1/2a Clinical Development of CD19xCD22 bivalent CAR-T therapy
Aug 24, 2026 · GlobeNewsWire
Liminatus Pharma, Inc. Announces Reverse Stock Split of its Common Stock
Aug 18, 2026 · GlobeNewsWire
SEC Filings (59)
Last two years from EDGAR. Insider Form 4s are on the Ownership tab.
| Filed | Form | What it is | Links |
|---|---|---|---|
| Nov 3, 2026 | 8-K | Material event | DocumentIndex |
| Sep 29, 2026 | 8-K | Material event | DocumentIndex |
| Aug 18, 2026 | 8-K | Material event | DocumentIndex |
| Aug 14, 2026 | 10-Q | Quarterly report | DocumentIndex |
| Aug 4, 2026 | 8-K | Material event | DocumentIndex |
| Jul 30, 2026 | 8-K | Material event | DocumentIndex |
| Jul 24, 2026 | 8-K | Material event | DocumentIndex |
| Jul 22, 2026 | SC 13G | Passive 5%+ stake | DocumentIndex |
| Jul 14, 2026 | SC 13D/A | Activist / 5%+ stake | DocumentIndex |
| Jul 13, 2026 | DEF 14A | Proxy / shareholder vote | DocumentIndex |
| Jul 6, 2026 | SC 13G/A | Passive 5%+ stake | DocumentIndex |
| Jul 6, 2026 | 8-K | Material event | DocumentIndex |
| Jun 30, 2026 | PRE 14A | Proxy / shareholder vote | DocumentIndex |
| Jun 24, 2026 | S-1 | IPO / offering registration | DocumentIndex |
| Jun 18, 2026 | D | DocumentIndex | |
| Jun 3, 2026 | 8-K | Material event | DocumentIndex |
| Jun 3, 2026 | 424B3 | Offering prospectus | DocumentIndex |
| May 27, 2026 | 8-K | Material event | DocumentIndex |
| May 20, 2026 | 8-K | Material event | DocumentIndex |
| May 15, 2026 | 10-Q | Quarterly report | DocumentIndex |
| Mar 31, 2026 | 10-K | Annual report | DocumentIndex |
| Mar 4, 2026 | 8-K | Material event | DocumentIndex |
| Feb 20, 2026 | SC 13G | Passive 5%+ stake | DocumentIndex |
| Feb 18, 2026 | 8-K | Material event | DocumentIndex |
| Feb 18, 2026 | 424B4 | Offering prospectus | DocumentIndex |
| Feb 13, 2026 | EFFECT | DocumentIndex | |
| Feb 11, 2026 | S-1 | IPO / offering registration | DocumentIndex |
| Feb 9, 2026 | 8-K | Material event | DocumentIndex |
| Jan 26, 2026 | 8-K | Material event | DocumentIndex |
| Nov 25, 2025 | 8-K | Material event | DocumentIndex |
| Nov 14, 2025 | 10-Q | Quarterly report | DocumentIndex |
| Oct 6, 2025 | 10-Q | Quarterly report | DocumentIndex |
| Aug 25, 2025 | 8-K | Material event | DocumentIndex |
| Aug 15, 2025 | NT 10-Q | DocumentIndex | |
| Aug 14, 2025 | 8-K | Material event | DocumentIndex |
| Aug 13, 2025 | 424B3 | Offering prospectus | DocumentIndex |
| Aug 12, 2025 | EFFECT | DocumentIndex | |
| Jul 17, 2025 | 8-K | Material event | DocumentIndex |
| Jul 11, 2025 | 8-K | Material event | DocumentIndex |
| Jul 3, 2025 | 8-K | Material event | DocumentIndex |